{
"uri": "https://www.find-tender.service.gov.uk/api/1.0/ocdsRecordPackages/ocds-h6vhtk-06dcb3",
"publisher": {
"name": "Cabinet Office",
"scheme": "GB-GOR",
"uid": "D2",
"uri": "https://www.gov.uk/government/organisations/cabinet-office"
},
"publishedDate": "2026-10-13T11:51:32+01:00",
"license": "http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
"publicationPolicy": "https://www.gov.uk/government/publications/open-contracting",
"version": "1.1",
"extensions": [
"https://standard.open-contracting.org/profiles/eu/latest/en/extension.json",
"https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json",
"https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json",
"https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json",
"https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json",
"https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json",
"https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json",
"https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json",
"https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json"
],
"packages": [
"https://www.find-tender.service.gov.uk/api/1.0/ocdsRecordPackages/ocds-h6vhtk-06dcb3"
],
"records": [
{
"ocid": "ocds-h6vhtk-06dcb3",
"releases": [
{
"ocid": "ocds-h6vhtk-06dcb3",
"id": "074308-2026",
"date": "2026-08-05T15:30:15+01:00",
"tag": [
"planning"
],
"description": "The Preliminary Market Engagement Notice uses 85100000-0 Health services as the main CPV code as the engagement relates to a targeted screening programme and includes two clinical/diagnostic workstreams. Additional CPV codes included to reflect the specific workstreams: PSA laboratory processing & medical analysis, prostate MRI reporting, & digital decision resource/website development. The use of multiple CPV codes reflects the fact that this is one combined market engagement.
Please note the following CPV codes are being utilised as well for the early engagement (but are not PSR related):
World wide web (www) site design services
72413000
Internet and intranet software development services
72212220
IT services: consulting, software development, Internet and support
72000000
A separate, relevant PA23 early engagement notice has been released with all CPV codes as well.",
"initiationType": "tender",
"tender": {
"id": "C463159",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource",
"status": "planned",
"classification": {
"scheme": "CPV",
"id": "85145000",
"description": "Services provided by medical laboratories"
},
"mainProcurementCategory": "services",
"description": "NHS England is undertaking early market engagement to inform three separate requirements within the Targeted Prostate Cancer Screening Programme.",
"lots": [
{
"id": "1",
"description": "Preliminary Market Engagement / Early Market Engagement
NHS England is undertaking preliminary market engagement to inform three separate but connected requirements within the Targeted Prostate Cancer Screening Programme.
The proposed workstreams are:
1. PSA laboratory processing and pathway support;
2. prostate MRI reporting;
3. BRCA digital decision resource / website development and evaluation.
The programme is being developed to support targeted prostate cancer screening for men at increased risk, including men with a known pathogenic or likely pathogenic BRCA2 variant. The purpose of this engagement is to understand market capability, potential delivery models, mobilisation requirements, key risks, pricing assumptions, digital and information governance considerations, pathway interfaces and route-to-market options.
The workstreams involve different capabilities and provider markets. NHS England may procure the requirements separately, and different procurement routes may apply to different workstreams. NHS England is currently assessing the most appropriate route to market for each workstream. Subject to completion of the relevant approvals and assessments, Workstreams 1 and 2 are anticipated to be procured under the Provider Selection Regime where confirmed as being within scope of that regime. Workstream 3 is anticipated to be procured in accordance with the Procurement Act 2023.
This engagement is not a call for competition, does not commence a procurement process, and does not commit NHS England to any procurement, route to market, contract award or level of expenditure. Participation in this engagement is not required in order to participate in any future procurement process, and non-participation will not prevent participation in any future opportunity.
Suppliers may respond to one, two or all three workstreams, depending on their capability and interest.
The Preliminary Market Engagement Notice uses 85100000-0 Health services as the main CPV code because the engagement relates to a targeted screening programme and includes two clinical/diagnostic workstreams. Additional CPV codes have been included to reflect the specific workstreams: PSA laboratory processing and medical analysis, prostate MRI reporting, and digital decision resource / website development. The use of multiple CPV codes reflects the fact that this is one combined market engagement exercise only; the workstreams may be procured separately and may follow different procurement routes following Commercial review.",
"status": "planned"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
{
"scheme": "CPV",
"id": "85150000",
"description": "Medical imaging services"
},
{
"scheme": "CPV",
"id": "85148000",
"description": "Medical analysis services"
},
{
"scheme": "CPV",
"id": "85145000",
"description": "Services provided by medical laboratories"
}
],
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"communication": {
"futureNoticeDate": "2026-12-07T00:00:00Z",
"atypicalToolUrl": "https://atamis-1928.my.site.com/s/Welcome"
},
"coveredBy": [
"GPA"
]
},
"parties": [
{
"name": "NHS England",
"id": "GB-FTS-130973",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "Wellington House, 133-135 Waterloo Rd",
"locality": "London",
"region": "UKI",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "NHS England",
"email": "england.commercialqueries@nhs.net"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
}
],
"buyer": {
"id": "GB-FTS-130973",
"name": "NHS England"
},
"language": "en"
},
{
"ocid": "ocds-h6vhtk-06dcb3",
"id": "096478-2026",
"date": "2026-10-13T11:51:03+01:00",
"tag": [
"tender"
],
"description": "This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award.",
"initiationType": "tender",
"tender": {
"id": "C473436",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Targeted Prostate Cancer Screening Programme - MRI Reporting Service",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "85150000",
"description": "Medical imaging services"
},
"mainProcurementCategory": "services",
"description": "The Contracting Authority is procuring a targeted prostate cancer screening pathway with a focus on men at increased risk due to an inherited BRCA2 variant utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023.
NHS England is seeking a provider to deliver a national centralised Prostate MRI Reporting Service to support the Targeted Prostate Cancer Screening Programme for England.
The service will provide specialist reporting of prostate MRI examinations for Programme Participants requiring MRI following an above-threshold PSA result. The scope will include image receipt or access, case acceptance, specialist human double reporting, lesion delineation where required, expert arbitration, structured report production and authorisation, secure report return, acknowledgement and Failsafe arrangements, quality assurance, escalation, Programme data reporting, audit and governance participation.
Diagnostic MRI scanning is outside the scope of this procurement. The procurement also excludes PSA testing, biopsy delivery, urology treatment, BRCA digital decision-resource development, BRCA genetic testing and development of the national Programme IT system.",
"value": {
"amount": 143654.56,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"description": "As part of this process, the Contracting Authority would like to invite interested parties to read and complete our Invitation to Tender within our e-Tendering System Atamis, https://atamis-1928.my.site.com/s/Welcome. This service will be competed under The Health Care Services (Provider Selection Regime) Regulations 2023 and will not be competed via Public Contract Regulations 2015 or via the Procurement Act 2023.
The Contracting Authority will be using Atamis, the Contracting Authority’s e-Tendering system for this procurement exercise. For further information, the ITT documentation can be found via the 'Live Opportunities' list on the e-tendering system.
Only Tenders which pass the applicable compliance checks and all applicable Pass/Fail requirements in Questionnaire 1 – the Basic Selection Criteria Questionnaire in accordance with Document 1 – ITT Instructions, will proceed to Stage 2 evaluation.
Stage 1 (Compliance and Basic Selection Criteria Questionnaire)
Compliance checks will be completed to ensure tenders are completed as per the ITT instructions. The Basic Selection Criteria Questionnaire will evaluate the Basic Selection Criteria. The questions will be evaluated on a Pass/Fail or for information only basis and can be found in Document 3.
Stage 2 (Quality, Social Value and Commercial Envelope)
This will be the evaluation of the Quality and Commercial envelope which contains the Key Criteria questions and can be found in Document 4 (Quality and Social Value Envelope) and Document 5 (Commercial Envelope). Scores from Stage 2 evaluation will form 20% of the final score at Stage 3 evaluation.
The Key Criteria (as outlined in PSR Regulation 5) for Stage 2 will be evaluated as outlined below:
1. National MRI reporting service model and governance - 8%
National service model, governance, accountability, subcontracting/reporting networks and pathway interfaces.
2. Reader workforce, competence, capacity and onboarding - 16%
Reader credentials and experience, training, QA, workforce capacity, resilience and performance management.
3. Image receipt, Scanning Organisation interface and digital interoperability - 12%
Image transfer/access, interfaces, matching, case acceptance, image quality, reconciliation, downtime and IG.
4. Reporting protocol, double reading, arbitration and structured report - 16%
Human double reading, arbitration, lesion delineation, Structured Report, incidental findings, QA and reporting compliance.
5. Report return, urgent findings, Failsafe and onward pathway liaison - 10%
Report return/acknowledgement, urgent findings, failed handoffs, Failsafe, escalation and downstream liaison.
6. Mobilisation, performance monitoring, resilience and business continuity - 8%
Mobilisation, onboarding, testing, KPIs, audit, capacity, BCP, recovery and reconciliation.
7. Social Value – equitable access, workforce sustainability and low-carbon delivery – 10%
Key areas assessed: equitable access to specialist MRI reporting, sustainable specialist workforce, fair work, training/wellbeing, ethical subcontracting, remote/digital delivery and low-carbon operational practices.
PSR Key Criteria
In accordance with Regulation 5 of the Health Care Services (Provider Selection Regime) Regulations 2023, the award criteria collectively assess all five PSR Key Criteria as follows:
Quality and Innovation – assessed through Questions 1–6 of the Quality Envelope, including service quality, specialist reader capability, digital interoperability, reporting methodology, clinical Failsafe arrangements, mobilisation and resilience.
Value – assessed through the Commercial Envelope, weighted at 20%.
Integration, Collaboration and Service Sustainability – assessed principally through Questions 1, 2, 3, 5 and 6, including governance, specialist workforce sustainability, Scanning Organisation interfaces, digital interoperability, pathway handoffs, capacity and business continuity.
Improving Access, Reducing Health Inequalities and Facilitating Choice – assessed principally through Questions 1, 3, 5 and 7, including national access to specialist reporting, Scanning Organisation connectivity, Failsafe/pathway liaison and additional equitable-access commitments.
Social Value – assessed through Question 7, weighted at 10%.
Stage 2 - Commercial Envelope - 20%
This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award.",
"value": {
"amount": 143654.56,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 780
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://atamis-1928.my.site.com/s/Welcome",
"communication": {
"atypicalToolUrl": "https://atamis-1928.my.site.com/s/Welcome"
},
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Applicants will be assessed in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 on the basis of the information provided in response to the Basic Selection Criteria Questionnaire (assessment Stage 1).",
"appliesTo": [
"supplier"
]
},
{
"type": "economic",
"description": "Selection criteria as stated in the procurement documents.",
"minimum": "Selection criteria as stated in the procurement documents.",
"appliesTo": [
"supplier"
]
}
]
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2026-11-10T12:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"endDate": "2027-03-01T23:59:59Z"
}
},
"awardPeriod": {
"startDate": "2026-10-13T12:00:00+01:00"
},
"bidOpening": {
"date": "2026-10-13T12:00:00+01:00"
},
"hasRecurrence": false
},
"parties": [
{
"name": "NHS England",
"id": "GB-FTS-130973",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "Wellington House, 133-135 Waterloo Rd",
"locality": "London",
"region": "UKI",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "NHS England",
"email": "england.commercialqueries@nhs.net",
"url": "https://atamis-1928.my.site.com/s/Welcome"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"name": "Independent patient choice and procurement panel",
"id": "GB-FTS-133554",
"identifier": {
"legalName": "Independent patient choice and procurement panel"
},
"address": {
"streetAddress": "Wellington House",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-130973",
"name": "NHS England"
},
"language": "en"
},
{
"ocid": "ocds-h6vhtk-06dcb3",
"id": "096480-2026",
"date": "2026-10-13T11:51:31+01:00",
"tag": [
"tender"
],
"description": "This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award.",
"initiationType": "tender",
"tender": {
"id": "C473446",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "85111810",
"description": "Blood analysis services"
},
"mainProcurementCategory": "services",
"description": "The Contracting Authority is procuring a targeted prostate cancer screening pathway with a focus on men at increased risk due to an inherited BRCA2 variant utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023.
NHS England is seeking a provider to deliver a national Prostate Specific Antigen (PSA) Laboratory Processing and Virtual Screening Pathway Coordination service to support the Targeted Prostate Cancer Screening Programme for England.
The service will include PSA Sample logistics from the agreed collection handoff point, Sample receipt and accessioning, PSA processing and result authorisation, secure result transmission, consumables provision, Sample and pathway tracking, Failsafe management, Programme data and reporting, and Virtual Screening Pathway Coordination. The VSPC function will include coordination of MRI appointments following an above-threshold PSA result and coordination of biopsy/urology appointments following an actionable MRI result, within the Authority-approved pathway and responsibility arrangements.
The procurement does not include delivery of diagnostic MRI scanning or MRI reporting, biopsy procedures, urology treatment, BRCA digital decision-resource development, BRCA genetic testing or development of the national Programme IT system. Clinical delivery and acceptance of onward referrals remain with the relevant commissioned clinical providers.",
"value": {
"amount": 238607.89999999999,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"description": "As part of this process, the Contracting Authority would like to invite interested parties to read and complete our Invitation to Tender within our e-Tendering System Atamis, https://atamis-1928.my.site.com/s/Welcome. This service will be competed under The Health Care Services (Provider Selection Regime) Regulations 2023 and will not be competed via Public Contract Regulations 2015 or via the Procurement Act 2023.
The Contracting Authority will be using Atamis, the Contracting Authority’s e-Tendering system for this procurement exercise. For further information, the ITT documentation can be found via the 'Live Opportunities' list on the e-tendering system.
Only Tenders which pass the applicable compliance checks and all applicable Pass/Fail requirements in Questionnaire 1 – the Basic Selection Criteria Questionnaire in accordance with Document 1 – ITT Instructions, will proceed to Stage 2 evaluation.
Stage 1 (Compliance and Basic Selection Criteria Questionnaire)
Compliance checks will be completed to ensure tenders are completed as per the ITT instructions. The Basic Selection Criteria Questionnaire will evaluate the Basic Selection Criteria. The questions will be evaluated on a Pass/Fail or for information only basis and can be found in Document 3.
Stage 2 (Quality, Social Value and Commercial Envelope)
This will be the evaluation of the Quality and Commercial envelope which contains the Key Criteria questions and can be found in Document 4 (Quality and Social Value Envelope) and Document 5 (Commercial Envelope). Scores from Stage 2 evaluation will form 100% of the final score.
The Key Criteria (as outlined in PSR Regulation 5) for Stage 2 will be evaluated as outlined below:
Stage 2 - Quality & Social Value Envelope - 80%
1. Service model, accountability and pathway operation - 10%
National delivery model, governance, roles/responsibilities, handoffs, escalation and VSPC accountability.
2. Collection packs, sample-taking site interface and logistics - 12%\t
Consumables, site onboarding, Sample handoff, transport, chain of custody, logistics resilience and exceptions.
3. Laboratory capability, assay control, accreditation and analytical quality - 16%
Laboratory capability, UKAS/ISO 15189, approved PSA assay, IQC/EQA, calibration, validation and analytical consistency.
4. Result reporting, National IT interface, data and management information- 10%
Result transmission, interfaces, acknowledgements, data quality, reconciliation, downtime, MI and reporting.
5. Failsafe, invalid Samples, repeat collection and onward MRI/biopsy coordination - 14%
Failsafe, failed/invalid Samples, repeats, MRI coordination, biopsy/urology handoff, acknowledgement and escalation.
6. Mobilisation, capacity, resilience and business continuity - 8%
Mobilisation, readiness, capacity, testing, resilience, BCP, recovery, transition and exit.
7. Social Value – fair work, sustainable delivery and additional equitable-access benefits – 10%
PSR Key Criteria
In accordance with Regulation 5 of the Health Care Services (Provider Selection Regime) Regulations 2023, the award criteria collectively assess all five PSR Key Criteria as follows:
Quality and Innovation – assessed through Questions 1–6 of the Quality Envelope, including service quality, logistics, laboratory capability, analytical quality, digital/result reporting, Failsafe arrangements, mobilisation, capacity and resilience.
Value – assessed through the Commercial Envelope, weighted at 20%.
Integration, Collaboration and Service Sustainability – assessed principally through Questions 1, 4, 5 and 6, including governance, pathway interfaces, National IT integration, handoffs, onward coordination, capacity, resilience and business continuity.
Improving Access, Reducing Health Inequalities and Facilitating Choice – assessed principally through Questions 2, 5 and 7, including equitable national logistics and access, remote-area arrangements, Failsafe/pathway coordination and additional equitable-access commitments.
Social Value – assessed through Question 7, weighted at 10%.
Stage 2 - Commercial Envelope - 20%
This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award.",
"value": {
"amount": 238607.89999999999,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 780
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85145000",
"description": "Services provided by medical laboratories"
}
],
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://atamis-1928.my.site.com/s/Welcome",
"communication": {
"atypicalToolUrl": "https://atamis-1928.my.site.com/s/Welcome"
},
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Applicants will be assessed in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 on the basis of the information provided in response to the Basic Selection Criteria Questionnaire (assessment Stage 1).",
"appliesTo": [
"supplier"
]
},
{
"type": "economic",
"description": "Selection criteria as stated in the procurement documents.",
"appliesTo": [
"supplier"
]
},
{
"type": "technical",
"description": "Selection criteria as stated in the procurement documents.",
"appliesTo": [
"supplier"
]
}
]
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2026-11-10T12:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"endDate": "2027-03-01T23:59:59Z"
}
},
"awardPeriod": {
"startDate": "2026-10-13T12:00:00+01:00"
},
"bidOpening": {
"date": "2026-10-13T12:00:00+01:00"
},
"hasRecurrence": false
},
"parties": [
{
"name": "NHS England",
"id": "GB-FTS-130973",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "Wellington House, 133-135 Waterloo Rd",
"locality": "London",
"region": "UKI",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "NHS England",
"email": "england.commercialqueries@nhs.net",
"url": "https://atamis-1928.my.site.com/s/Welcome"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"name": "Independent patient choice and procurement panel",
"id": "GB-FTS-133554",
"identifier": {
"legalName": "Independent patient choice and procurement panel"
},
"address": {
"streetAddress": "Wellington House",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-130973",
"name": "NHS England"
},
"language": "en"
}
],
"compiledRelease": {
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-06dcb3-2026-10-13T11:51:31+01:00",
"date": "2026-10-13T11:51:31+01:00",
"ocid": "ocds-h6vhtk-06dcb3",
"description": "This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award.",
"initiationType": "tender",
"tender": {
"id": "C473446",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "85111810",
"description": "Blood analysis services"
},
"mainProcurementCategory": "services",
"description": "The Contracting Authority is procuring a targeted prostate cancer screening pathway with a focus on men at increased risk due to an inherited BRCA2 variant utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023.
NHS England is seeking a provider to deliver a national Prostate Specific Antigen (PSA) Laboratory Processing and Virtual Screening Pathway Coordination service to support the Targeted Prostate Cancer Screening Programme for England.
The service will include PSA Sample logistics from the agreed collection handoff point, Sample receipt and accessioning, PSA processing and result authorisation, secure result transmission, consumables provision, Sample and pathway tracking, Failsafe management, Programme data and reporting, and Virtual Screening Pathway Coordination. The VSPC function will include coordination of MRI appointments following an above-threshold PSA result and coordination of biopsy/urology appointments following an actionable MRI result, within the Authority-approved pathway and responsibility arrangements.
The procurement does not include delivery of diagnostic MRI scanning or MRI reporting, biopsy procedures, urology treatment, BRCA digital decision-resource development, BRCA genetic testing or development of the national Programme IT system. Clinical delivery and acceptance of onward referrals remain with the relevant commissioned clinical providers.",
"lots": [
{
"id": "1",
"description": "As part of this process, the Contracting Authority would like to invite interested parties to read and complete our Invitation to Tender within our e-Tendering System Atamis, https://atamis-1928.my.site.com/s/Welcome. This service will be competed under The Health Care Services (Provider Selection Regime) Regulations 2023 and will not be competed via Public Contract Regulations 2015 or via the Procurement Act 2023.
The Contracting Authority will be using Atamis, the Contracting Authority’s e-Tendering system for this procurement exercise. For further information, the ITT documentation can be found via the 'Live Opportunities' list on the e-tendering system.
Only Tenders which pass the applicable compliance checks and all applicable Pass/Fail requirements in Questionnaire 1 – the Basic Selection Criteria Questionnaire in accordance with Document 1 – ITT Instructions, will proceed to Stage 2 evaluation.
Stage 1 (Compliance and Basic Selection Criteria Questionnaire)
Compliance checks will be completed to ensure tenders are completed as per the ITT instructions. The Basic Selection Criteria Questionnaire will evaluate the Basic Selection Criteria. The questions will be evaluated on a Pass/Fail or for information only basis and can be found in Document 3.
Stage 2 (Quality, Social Value and Commercial Envelope)
This will be the evaluation of the Quality and Commercial envelope which contains the Key Criteria questions and can be found in Document 4 (Quality and Social Value Envelope) and Document 5 (Commercial Envelope). Scores from Stage 2 evaluation will form 100% of the final score.
The Key Criteria (as outlined in PSR Regulation 5) for Stage 2 will be evaluated as outlined below:
Stage 2 - Quality & Social Value Envelope - 80%
1. Service model, accountability and pathway operation - 10%
National delivery model, governance, roles/responsibilities, handoffs, escalation and VSPC accountability.
2. Collection packs, sample-taking site interface and logistics - 12%\t
Consumables, site onboarding, Sample handoff, transport, chain of custody, logistics resilience and exceptions.
3. Laboratory capability, assay control, accreditation and analytical quality - 16%
Laboratory capability, UKAS/ISO 15189, approved PSA assay, IQC/EQA, calibration, validation and analytical consistency.
4. Result reporting, National IT interface, data and management information- 10%
Result transmission, interfaces, acknowledgements, data quality, reconciliation, downtime, MI and reporting.
5. Failsafe, invalid Samples, repeat collection and onward MRI/biopsy coordination - 14%
Failsafe, failed/invalid Samples, repeats, MRI coordination, biopsy/urology handoff, acknowledgement and escalation.
6. Mobilisation, capacity, resilience and business continuity - 8%
Mobilisation, readiness, capacity, testing, resilience, BCP, recovery, transition and exit.
7. Social Value – fair work, sustainable delivery and additional equitable-access benefits – 10%
PSR Key Criteria
In accordance with Regulation 5 of the Health Care Services (Provider Selection Regime) Regulations 2023, the award criteria collectively assess all five PSR Key Criteria as follows:
Quality and Innovation – assessed through Questions 1–6 of the Quality Envelope, including service quality, logistics, laboratory capability, analytical quality, digital/result reporting, Failsafe arrangements, mobilisation, capacity and resilience.
Value – assessed through the Commercial Envelope, weighted at 20%.
Integration, Collaboration and Service Sustainability – assessed principally through Questions 1, 4, 5 and 6, including governance, pathway interfaces, National IT integration, handoffs, onward coordination, capacity, resilience and business continuity.
Improving Access, Reducing Health Inequalities and Facilitating Choice – assessed principally through Questions 2, 5 and 7, including equitable national logistics and access, remote-area arrangements, Failsafe/pathway coordination and additional equitable-access commitments.
Social Value – assessed through Question 7, weighted at 10%.
Stage 2 - Commercial Envelope - 20%
This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award.",
"status": "active",
"value": {
"amount": 238607.89999999999,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 780
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85145000",
"description": "Services provided by medical laboratories"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"communication": {
"futureNoticeDate": "2026-12-07T00:00:00Z",
"atypicalToolUrl": "https://atamis-1928.my.site.com/s/Welcome"
},
"coveredBy": [
"GPA"
],
"value": {
"amount": 238607.89999999999,
"currency": "GBP"
},
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://atamis-1928.my.site.com/s/Welcome",
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Applicants will be assessed in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 on the basis of the information provided in response to the Basic Selection Criteria Questionnaire (assessment Stage 1).",
"appliesTo": [
"supplier"
]
},
{
"type": "economic",
"description": "Selection criteria as stated in the procurement documents.",
"appliesTo": [
"supplier"
]
},
{
"type": "technical",
"description": "Selection criteria as stated in the procurement documents.",
"appliesTo": [
"supplier"
]
}
]
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"tenderPeriod": {
"endDate": "2026-11-10T12:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"endDate": "2027-03-01T23:59:59Z"
}
},
"awardPeriod": {
"startDate": "2026-10-13T12:00:00+01:00"
},
"bidOpening": {
"date": "2026-10-13T12:00:00+01:00"
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-FTS-130973",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "Wellington House, 133-135 Waterloo Rd",
"locality": "London",
"region": "UKI",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "NHS England",
"email": "england.commercialqueries@nhs.net",
"url": "https://atamis-1928.my.site.com/s/Welcome"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-133554",
"name": "Independent patient choice and procurement panel",
"identifier": {
"legalName": "Independent patient choice and procurement panel"
},
"address": {
"streetAddress": "Wellington House",
"locality": "London",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-130973",
"name": "NHS England"
},
"language": "en"
},
"versionedRelease": {
"ocid": "ocds-h6vhtk-06dcb3",
"description": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "The Preliminary Market Engagement Notice uses 85100000-0 Health services as the main CPV code as the engagement relates to a targeted screening programme and includes two clinical/diagnostic workstreams. Additional CPV codes included to reflect the specific workstreams: PSA laboratory processing & medical analysis, prostate MRI reporting, & digital decision resource/website development. The use of multiple CPV codes reflects the fact that this is one combined market engagement.
Please note the following CPV codes are being utilised as well for the early engagement (but are not PSR related):
World wide web (www) site design services
72413000
Internet and intranet software development services
72212220
IT services: consulting, software development, Internet and support
72000000
A separate, relevant PA23 early engagement notice has been released with all CPV codes as well."
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award."
}
],
"initiationType": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "tender"
}
],
"tender": {
"id": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "C463159"
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "C473436"
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": "C473446"
}
],
"legalBasis": {
"id": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "32014L0024"
}
],
"scheme": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "CELEX"
}
]
},
"title": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource"
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "Targeted Prostate Cancer Screening Programme - MRI Reporting Service"
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": "Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service"
}
],
"status": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "planned"
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "active"
}
],
"classification": {
"scheme": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "CPV"
}
],
"id": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "85145000"
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "85150000"
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": "85111810"
}
],
"description": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "Services provided by medical laboratories"
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "Medical imaging services"
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": "Blood analysis services"
}
]
},
"mainProcurementCategory": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "services"
}
],
"description": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "NHS England is undertaking early market engagement to inform three separate requirements within the Targeted Prostate Cancer Screening Programme."
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "The Contracting Authority is procuring a targeted prostate cancer screening pathway with a focus on men at increased risk due to an inherited BRCA2 variant utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023.
NHS England is seeking a provider to deliver a national centralised Prostate MRI Reporting Service to support the Targeted Prostate Cancer Screening Programme for England.
The service will provide specialist reporting of prostate MRI examinations for Programme Participants requiring MRI following an above-threshold PSA result. The scope will include image receipt or access, case acceptance, specialist human double reporting, lesion delineation where required, expert arbitration, structured report production and authorisation, secure report return, acknowledgement and Failsafe arrangements, quality assurance, escalation, Programme data reporting, audit and governance participation.
Diagnostic MRI scanning is outside the scope of this procurement. The procurement also excludes PSA testing, biopsy delivery, urology treatment, BRCA digital decision-resource development, BRCA genetic testing and development of the national Programme IT system."
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": "The Contracting Authority is procuring a targeted prostate cancer screening pathway with a focus on men at increased risk due to an inherited BRCA2 variant utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023.
NHS England is seeking a provider to deliver a national Prostate Specific Antigen (PSA) Laboratory Processing and Virtual Screening Pathway Coordination service to support the Targeted Prostate Cancer Screening Programme for England.
The service will include PSA Sample logistics from the agreed collection handoff point, Sample receipt and accessioning, PSA processing and result authorisation, secure result transmission, consumables provision, Sample and pathway tracking, Failsafe management, Programme data and reporting, and Virtual Screening Pathway Coordination. The VSPC function will include coordination of MRI appointments following an above-threshold PSA result and coordination of biopsy/urology appointments following an actionable MRI result, within the Authority-approved pathway and responsibility arrangements.
The procurement does not include delivery of diagnostic MRI scanning or MRI reporting, biopsy procedures, urology treatment, BRCA digital decision-resource development, BRCA genetic testing or development of the national Programme IT system. Clinical delivery and acceptance of onward referrals remain with the relevant commissioned clinical providers."
}
],
"lots": [
{
"id": "1",
"description": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "Preliminary Market Engagement / Early Market Engagement
NHS England is undertaking preliminary market engagement to inform three separate but connected requirements within the Targeted Prostate Cancer Screening Programme.
The proposed workstreams are:
1. PSA laboratory processing and pathway support;
2. prostate MRI reporting;
3. BRCA digital decision resource / website development and evaluation.
The programme is being developed to support targeted prostate cancer screening for men at increased risk, including men with a known pathogenic or likely pathogenic BRCA2 variant. The purpose of this engagement is to understand market capability, potential delivery models, mobilisation requirements, key risks, pricing assumptions, digital and information governance considerations, pathway interfaces and route-to-market options.
The workstreams involve different capabilities and provider markets. NHS England may procure the requirements separately, and different procurement routes may apply to different workstreams. NHS England is currently assessing the most appropriate route to market for each workstream. Subject to completion of the relevant approvals and assessments, Workstreams 1 and 2 are anticipated to be procured under the Provider Selection Regime where confirmed as being within scope of that regime. Workstream 3 is anticipated to be procured in accordance with the Procurement Act 2023.
This engagement is not a call for competition, does not commence a procurement process, and does not commit NHS England to any procurement, route to market, contract award or level of expenditure. Participation in this engagement is not required in order to participate in any future procurement process, and non-participation will not prevent participation in any future opportunity.
Suppliers may respond to one, two or all three workstreams, depending on their capability and interest.
The Preliminary Market Engagement Notice uses 85100000-0 Health services as the main CPV code because the engagement relates to a targeted screening programme and includes two clinical/diagnostic workstreams. Additional CPV codes have been included to reflect the specific workstreams: PSA laboratory processing and medical analysis, prostate MRI reporting, and digital decision resource / website development. The use of multiple CPV codes reflects the fact that this is one combined market engagement exercise only; the workstreams may be procured separately and may follow different procurement routes following Commercial review."
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "As part of this process, the Contracting Authority would like to invite interested parties to read and complete our Invitation to Tender within our e-Tendering System Atamis, https://atamis-1928.my.site.com/s/Welcome. This service will be competed under The Health Care Services (Provider Selection Regime) Regulations 2023 and will not be competed via Public Contract Regulations 2015 or via the Procurement Act 2023.
The Contracting Authority will be using Atamis, the Contracting Authority’s e-Tendering system for this procurement exercise. For further information, the ITT documentation can be found via the 'Live Opportunities' list on the e-tendering system.
Only Tenders which pass the applicable compliance checks and all applicable Pass/Fail requirements in Questionnaire 1 – the Basic Selection Criteria Questionnaire in accordance with Document 1 – ITT Instructions, will proceed to Stage 2 evaluation.
Stage 1 (Compliance and Basic Selection Criteria Questionnaire)
Compliance checks will be completed to ensure tenders are completed as per the ITT instructions. The Basic Selection Criteria Questionnaire will evaluate the Basic Selection Criteria. The questions will be evaluated on a Pass/Fail or for information only basis and can be found in Document 3.
Stage 2 (Quality, Social Value and Commercial Envelope)
This will be the evaluation of the Quality and Commercial envelope which contains the Key Criteria questions and can be found in Document 4 (Quality and Social Value Envelope) and Document 5 (Commercial Envelope). Scores from Stage 2 evaluation will form 20% of the final score at Stage 3 evaluation.
The Key Criteria (as outlined in PSR Regulation 5) for Stage 2 will be evaluated as outlined below:
1. National MRI reporting service model and governance - 8%
National service model, governance, accountability, subcontracting/reporting networks and pathway interfaces.
2. Reader workforce, competence, capacity and onboarding - 16%
Reader credentials and experience, training, QA, workforce capacity, resilience and performance management.
3. Image receipt, Scanning Organisation interface and digital interoperability - 12%
Image transfer/access, interfaces, matching, case acceptance, image quality, reconciliation, downtime and IG.
4. Reporting protocol, double reading, arbitration and structured report - 16%
Human double reading, arbitration, lesion delineation, Structured Report, incidental findings, QA and reporting compliance.
5. Report return, urgent findings, Failsafe and onward pathway liaison - 10%
Report return/acknowledgement, urgent findings, failed handoffs, Failsafe, escalation and downstream liaison.
6. Mobilisation, performance monitoring, resilience and business continuity - 8%
Mobilisation, onboarding, testing, KPIs, audit, capacity, BCP, recovery and reconciliation.
7. Social Value – equitable access, workforce sustainability and low-carbon delivery – 10%
Key areas assessed: equitable access to specialist MRI reporting, sustainable specialist workforce, fair work, training/wellbeing, ethical subcontracting, remote/digital delivery and low-carbon operational practices.
PSR Key Criteria
In accordance with Regulation 5 of the Health Care Services (Provider Selection Regime) Regulations 2023, the award criteria collectively assess all five PSR Key Criteria as follows:
Quality and Innovation – assessed through Questions 1–6 of the Quality Envelope, including service quality, specialist reader capability, digital interoperability, reporting methodology, clinical Failsafe arrangements, mobilisation and resilience.
Value – assessed through the Commercial Envelope, weighted at 20%.
Integration, Collaboration and Service Sustainability – assessed principally through Questions 1, 2, 3, 5 and 6, including governance, specialist workforce sustainability, Scanning Organisation interfaces, digital interoperability, pathway handoffs, capacity and business continuity.
Improving Access, Reducing Health Inequalities and Facilitating Choice – assessed principally through Questions 1, 3, 5 and 7, including national access to specialist reporting, Scanning Organisation connectivity, Failsafe/pathway liaison and additional equitable-access commitments.
Social Value – assessed through Question 7, weighted at 10%.
Stage 2 - Commercial Envelope - 20%
This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award."
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": "As part of this process, the Contracting Authority would like to invite interested parties to read and complete our Invitation to Tender within our e-Tendering System Atamis, https://atamis-1928.my.site.com/s/Welcome. This service will be competed under The Health Care Services (Provider Selection Regime) Regulations 2023 and will not be competed via Public Contract Regulations 2015 or via the Procurement Act 2023.
The Contracting Authority will be using Atamis, the Contracting Authority’s e-Tendering system for this procurement exercise. For further information, the ITT documentation can be found via the 'Live Opportunities' list on the e-tendering system.
Only Tenders which pass the applicable compliance checks and all applicable Pass/Fail requirements in Questionnaire 1 – the Basic Selection Criteria Questionnaire in accordance with Document 1 – ITT Instructions, will proceed to Stage 2 evaluation.
Stage 1 (Compliance and Basic Selection Criteria Questionnaire)
Compliance checks will be completed to ensure tenders are completed as per the ITT instructions. The Basic Selection Criteria Questionnaire will evaluate the Basic Selection Criteria. The questions will be evaluated on a Pass/Fail or for information only basis and can be found in Document 3.
Stage 2 (Quality, Social Value and Commercial Envelope)
This will be the evaluation of the Quality and Commercial envelope which contains the Key Criteria questions and can be found in Document 4 (Quality and Social Value Envelope) and Document 5 (Commercial Envelope). Scores from Stage 2 evaluation will form 100% of the final score.
The Key Criteria (as outlined in PSR Regulation 5) for Stage 2 will be evaluated as outlined below:
Stage 2 - Quality & Social Value Envelope - 80%
1. Service model, accountability and pathway operation - 10%
National delivery model, governance, roles/responsibilities, handoffs, escalation and VSPC accountability.
2. Collection packs, sample-taking site interface and logistics - 12%\t
Consumables, site onboarding, Sample handoff, transport, chain of custody, logistics resilience and exceptions.
3. Laboratory capability, assay control, accreditation and analytical quality - 16%
Laboratory capability, UKAS/ISO 15189, approved PSA assay, IQC/EQA, calibration, validation and analytical consistency.
4. Result reporting, National IT interface, data and management information- 10%
Result transmission, interfaces, acknowledgements, data quality, reconciliation, downtime, MI and reporting.
5. Failsafe, invalid Samples, repeat collection and onward MRI/biopsy coordination - 14%
Failsafe, failed/invalid Samples, repeats, MRI coordination, biopsy/urology handoff, acknowledgement and escalation.
6. Mobilisation, capacity, resilience and business continuity - 8%
Mobilisation, readiness, capacity, testing, resilience, BCP, recovery, transition and exit.
7. Social Value – fair work, sustainable delivery and additional equitable-access benefits – 10%
PSR Key Criteria
In accordance with Regulation 5 of the Health Care Services (Provider Selection Regime) Regulations 2023, the award criteria collectively assess all five PSR Key Criteria as follows:
Quality and Innovation – assessed through Questions 1–6 of the Quality Envelope, including service quality, logistics, laboratory capability, analytical quality, digital/result reporting, Failsafe arrangements, mobilisation, capacity and resilience.
Value – assessed through the Commercial Envelope, weighted at 20%.
Integration, Collaboration and Service Sustainability – assessed principally through Questions 1, 4, 5 and 6, including governance, pathway interfaces, National IT integration, handoffs, onward coordination, capacity, resilience and business continuity.
Improving Access, Reducing Health Inequalities and Facilitating Choice – assessed principally through Questions 2, 5 and 7, including equitable national logistics and access, remote-area arrangements, Failsafe/pathway coordination and additional equitable-access commitments.
Social Value – assessed through Question 7, weighted at 10%.
Stage 2 - Commercial Envelope - 20%
This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award."
}
],
"status": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "planned"
},
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "active"
}
],
"value": {
"amount": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": 143654.56
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": 238607.89999999999
}
],
"currency": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "GBP"
}
]
},
"contractPeriod": {
"durationInDays": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": 780
}
]
},
"hasRenewal": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": false
}
],
"submissionTerms": {
"variantPolicy": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "notAllowed"
}
]
},
"hasOptions": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": false
}
]
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
{
"scheme": "CPV",
"id": "85150000",
"description": "Medical imaging services"
},
{
"scheme": "CPV",
"id": "85148000",
"description": "Medical analysis services"
},
{
"scheme": "CPV",
"id": "85145000",
"description": "Services provided by medical laboratories"
}
]
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": [
{
"scheme": "CPV",
"id": "85145000",
"description": "Services provided by medical laboratories"
}
]
}
],
"deliveryAddresses": [
{
"region": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "UK"
}
]
},
{
"region": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "UK"
}
]
},
{
"region": [
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": "UK"
}
]
}
],
"relatedLot": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "1"
}
]
}
],
"communication": {
"futureNoticeDate": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "2026-12-07T00:00:00Z"
}
],
"atypicalToolUrl": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "https://atamis-1928.my.site.com/s/Welcome"
}
]
},
"coveredBy": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": [
"GPA"
]
}
],
"value": {
"amount": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": 143654.56
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": 238607.89999999999
}
],
"currency": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "GBP"
}
]
},
"submissionMethod": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": [
"electronicSubmission",
"written"
]
}
],
"submissionMethodDetails": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "https://atamis-1928.my.site.com/s/Welcome"
}
],
"selectionCriteria": {
"criteria": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": [
{
"type": "suitability",
"description": "Applicants will be assessed in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 on the basis of the information provided in response to the Basic Selection Criteria Questionnaire (assessment Stage 1).",
"appliesTo": [
"supplier"
]
},
{
"type": "economic",
"description": "Selection criteria as stated in the procurement documents.",
"minimum": "Selection criteria as stated in the procurement documents.",
"appliesTo": [
"supplier"
]
}
]
},
{
"releaseID": "096480-2026",
"releaseDate": "2026-10-13T11:51:31+01:00",
"releaseTag": [
"tender"
],
"value": [
{
"type": "suitability",
"description": "Applicants will be assessed in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 on the basis of the information provided in response to the Basic Selection Criteria Questionnaire (assessment Stage 1).",
"appliesTo": [
"supplier"
]
},
{
"type": "economic",
"description": "Selection criteria as stated in the procurement documents.",
"appliesTo": [
"supplier"
]
},
{
"type": "technical",
"description": "Selection criteria as stated in the procurement documents.",
"appliesTo": [
"supplier"
]
}
]
}
]
},
"procurementMethod": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "open"
}
],
"procurementMethodDetails": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "Open procedure"
}
],
"tenderPeriod": {
"endDate": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "2026-11-10T12:00:00Z"
}
]
},
"submissionTerms": {
"languages": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": [
"en"
]
}
],
"bidValidityPeriod": {
"endDate": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "2027-03-01T23:59:59Z"
}
]
}
},
"awardPeriod": {
"startDate": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "2026-10-13T12:00:00+01:00"
}
]
},
"bidOpening": {
"date": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "2026-10-13T12:00:00+01:00"
}
]
},
"hasRecurrence": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": false
}
]
},
"parties": [
{
"id": "GB-FTS-130973",
"name": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "NHS England"
}
],
"identifier": {
"legalName": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "NHS England"
}
]
},
"address": {
"streetAddress": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "Wellington House, 133-135 Waterloo Rd"
}
],
"locality": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "London"
}
],
"region": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "UKI"
}
],
"postalCode": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "SE1 8UG"
}
],
"countryName": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "United Kingdom"
}
]
},
"contactPoint": {
"name": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "NHS England"
}
],
"email": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "england.commercialqueries@nhs.net"
}
],
"url": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "https://atamis-1928.my.site.com/s/Welcome"
}
]
},
"roles": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": [
"buyer"
]
}
],
"details": {
"url": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "https://www.england.nhs.uk/"
}
],
"buyerProfile": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "https://www.england.nhs.uk/"
}
],
"classifications": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
]
}
},
{
"id": "GB-FTS-133554",
"name": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "Independent patient choice and procurement panel"
}
],
"identifier": {
"legalName": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "Independent patient choice and procurement panel"
}
]
},
"address": {
"streetAddress": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "Wellington House"
}
],
"locality": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "London"
}
],
"postalCode": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "SE1 8UG"
}
],
"countryName": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": "United Kingdom"
}
]
},
"roles": [
{
"releaseID": "096478-2026",
"releaseDate": "2026-10-13T11:51:03+01:00",
"releaseTag": [
"tender"
],
"value": [
"reviewBody"
]
}
]
}
],
"buyer": {
"id": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "GB-FTS-130973"
}
],
"name": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "NHS England"
}
]
},
"language": [
{
"releaseID": "074308-2026",
"releaseDate": "2026-08-05T15:30:15+01:00",
"releaseTag": [
"planning"
],
"value": "en"
}
]
}
}
]
}